An Approach to Quantifying the Interaction between Behavioral and Transmission Clusters.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
10 04 2022
Historique:
received: 23 02 2022
revised: 05 04 2022
accepted: 06 04 2022
entrez: 23 4 2022
pubmed: 24 4 2022
medline: 27 4 2022
Statut: epublish

Résumé

We hypothesize that patterns of sexual behavior play a role in the conformation of transmission networks, i.e., the way you behave might influence whom you have sex with. If that was the case, behavioral grouping might in turn correlate with, and potentially predict transmission networking, e.g., proximity in a viral phylogeny. We rigorously present an intuitive approach to address this hypothesis by quantifying mapped interactions between groups defined by similarities in sexual behavior along a virus phylogeny while discussing power and sample size considerations. Data from the Swiss HIV Cohort Study on condom use and hepatitis C virus (HCV) sequences served as proof-of-concept. In this case, a strict inclusion criteria contrasting with low HCV prevalence hindered our possibilities to identify significant relationships. This manuscript serves as guide for studies aimed at characterizing interactions between behavioral patterns and transmission networks. Large transmission networks such as those of HIV or COVID-19 are prime candidates for applying this methodological approach.

Identifiants

pubmed: 35458514
pii: v14040784
doi: 10.3390/v14040784
pmc: PMC9032082
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Swiss National Science Foundation
ID : 177499, 324730_179567
Pays : Switzerland

Références

N Engl J Med. 2016 Sep 1;375(9):830-9
pubmed: 27424812
Clin Infect Dis. 2021 Jun 15;72(12):2175-2183
pubmed: 32300807
Clin Infect Dis. 2005 Aug 1;41(3):395-402
pubmed: 16007539
Arch Sex Behav. 2011 Aug;40(4):817-27
pubmed: 20878223
PLoS One. 2012;7(9):e44819
pubmed: 23024766
PLoS Med. 2008 Mar 18;5(3):e50
pubmed: 18351795
AIDS. 2015 Nov 28;29(18):2509-15
pubmed: 26372488
Clin Infect Dis. 2020 Jan 16;70(3):416-424
pubmed: 30874293
Lancet. 2019 Jun 15;393(10189):2428-2438
pubmed: 31056293
Open Forum Infect Dis. 2015 Jun 03;2(2):ofv077
pubmed: 26180827
Clin Infect Dis. 2019 Feb 1;68(4):561-568
pubmed: 30107494
Stat Commun Infect Dis. 2012 Nov 1;4(1):
pubmed: 24058722
JAMA. 2019 Feb 5;321(5):451-452
pubmed: 30629090
HIV Med. 2020 Apr;21(4):228-239
pubmed: 31849182
J Hepatol. 2017 Aug;67(2):255-262
pubmed: 28412290
Hepatology. 2016 Dec;64(6):1856-1869
pubmed: 27531615
Clin Infect Dis. 2019 Feb 1;68(4):569-576
pubmed: 30107485
HIV Med. 2018 Nov;19(10):688-697
pubmed: 30051600
Lancet. 2012 Jul 28;380(9839):388-99
pubmed: 22819659
AIDS. 2018 Jun 1;32(9):1185-1192
pubmed: 29596109
J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):e63-72
pubmed: 26866955
J Infect Dis. 2019 Jun 5;220(1):91-99
pubmed: 30759225
Curr Opin HIV AIDS. 2011 Nov;6(6):451-8
pubmed: 22001890
Clin Infect Dis. 2018 Apr 17;66(9):1360-1365
pubmed: 29186320
Curr HIV/AIDS Rep. 2014 Mar;11(1):81-92
pubmed: 24384832

Auteurs

Luisa Salazar-Vizcaya (L)

Department of Infectious Diseases, Bern University Hospital Inselspital, University of Bern, 3010 Bern, Switzerland.

Katharina Kusejko (K)

Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, 8091 Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.

Huldrych F Günthard (HF)

Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, 8091 Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.

Jürg Böni (J)

Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.

Karin J Metzner (KJ)

Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, 8091 Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.

Dominique L Braun (DL)

Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, 8091 Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.

Dunja Nicca (D)

Institute of Nursing Science, University of Basel, 4056 Basel, Switzerland.
Department of Public Health, Epidemiology, Biostatistics and Public Health Institute, University of Zurich, 8001 Zurich, Switzerland.

Enos Bernasconi (E)

Division of Infectious Diseases, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland.
University of Southern Switzerland, 6928 Manno, Switzerland.
Division of Infectious Diseases, Geneva University Hospitals, 1205 Geneva, Switzerland.

Alexandra Calmy (A)

Division of Infectious Diseases, Geneva University Hospitals, 1205 Geneva, Switzerland.

Katharine E A Darling (KEA)

Infectious Diseases Service, Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland.
University of Lausanne, 1015 Lausanne, Switzerland.

Gilles Wandeler (G)

Department of Infectious Diseases, Bern University Hospital Inselspital, University of Bern, 3010 Bern, Switzerland.

Roger D Kouyos (RD)

Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, 8091 Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.

Andri Rauch (A)

Department of Infectious Diseases, Bern University Hospital Inselspital, University of Bern, 3010 Bern, Switzerland.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH